почта: bd@sidmexinovia.com
Телефон: +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Главная >
Afanat 30 mg Tablet
Afanat 30 mg Tablet
Manufacturer/Marketed By : Natco Pharma Ltd
$47.82 $39.01
Afanat 30 mg Tablet is an effective treatment option for adults diagnosed with advanced or metastatic non-squamous non-small cell lung cancer, particularly for those whose tumors exhibit specific mutations such...
Сворачиваемый текст идеально подходит для длинных текстов, таких как абзацы и описания. Это отличный способ предоставить людям больше информации, сохраняя при этом лаконичность макета. Вы можете связать текст с чем угодно, включая внешний веб-сайт или другую страницу. Вы можете настроить текстовое поле так, чтобы оно разворачивалось и сворачивалось при щелчке пользователя, позволяя ему прочитать больше или меньше информации.
Afatinib 30 mg
Active Pharmaceutical Ingredient
Afanat 30 mg Tablet
47,82 $
39,01 $
Afanat 30 mg Tablet is an effective treatment option for adults diagnosed with advanced or metastatic non-squamous non-small cell lung cancer, particularly for those whose tumors exhibit specific mutations such as an epidermal growth factor receptor (EGFR) exon 19 deletion or L858R substitution mutation. This medication can be utilized as a first-line therapy or as a follow-up treatment for patients who have not responded to prior cytotoxic chemotherapy. It works by targeting the mutated EGFR, which plays a crucial role in cancer cell growth and survival, thereby inhibiting tumor progression. However, it is essential to note that Afanat is not recommended for children or adolescents, as its safety and efficacy in these populations have not been established. Patients should consult their healthcare provider to ensure this treatment aligns with their medical history and condition. Regular monitoring and follow-up are vital to assess the treatment's effectiveness and manage any potential side effects. By using Afanat 30 mg Tablet, patients can engage in a targeted approach to manage their lung cancer effectively and improve their overall treatment outcomes.
Active Pharmaceutical Ingredient
Применение
• Afanat 30 mg tablet is primarily used in the management of non-small cell lung cancer. This type of lung cancer is characterized by the growth of malignant cells in the lungs. The medication helps to inhibit cancer cell proliferation, potentially slowing the progression of the disease. Patients receiving Afanat 30 mg tablet may experience improved outcomes as part of their treatment plan.
• In addition to its role in treating non-small cell lung cancer, Afanat 30 mg tablet may also be utilized in combination with other therapies. This approach can enhance the overall effectiveness of cancer treatment regimens. Oncologists often prescribe Afanat 30 mg tablet to complement chemotherapy or radiation, aiming for a more comprehensive attack on the cancer. This strategy may lead to better management of symptoms and improved quality of life.
• Afanat 30 mg tablet is suitable for patients who are diagnosed with advanced stages of non-small cell lung cancer. As the disease progresses, treatment options may become limited, making Afanat a valuable choice. It is designed to target specific pathways involved in cancer growth, helping to control tumor development. Healthcare providers may recommend Afanat 30 mg tablet for its targeted action in these challenging cases.
• Patients may find that Afanat 30 mg tablet is an integral part of their long-term cancer management strategy. The medication is often prescribed as part of a personalized treatment plan tailored to the individual’s specific needs. By effectively addressing the complexities of non-small cell lung cancer, Afanat 30 mg tablet contributes to a holistic approach to patient care. Regular monitoring and follow-ups are essential to assess the effectiveness of the treatment.
Преимущества
Afanat 30 mg Tablet inhibits a protein called epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By inhibiting this protein, Afanat 30 mg Strip can help to slow the progression of cancer. Afatinib Tablet 30 mg may be able to help reduce the severity of cancer-related symptoms, such as pain and fatigue, which may improve the patient's overall quality of life. Afanat 30 mg Tablet may be used in combination with other cancer treatments, such as chemotherapy, to improve their effectiveness.
Побочные эффекты
Like all medications, Anti-cancer Drug Afanat can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Наиболее распространенные побочные эффекты
• Decreased appetite
• Burning sensation during urination
• Fatigue
• Ankles and feet swelling.
Распространенные побочные эффекты
• Vomiting
• Diarrhoea
• Mouth sores
• Acne
• Itchiness
• Rashes
Как использовать
Afanat 30 mg Tablet should be taken on an empty stomach at least one hour before or two hours after a meal. Always take Afanat Tablet exactly as directed by your doctor, including the recommended number and timing of tablets. Do not change your dose or stop this medicine without consulting your doctor. If you miss a dose, take it as soon as possible. If the next dose is scheduled within 12 hours, skip the missed dose and continue with the regular dosing regimen. It is not recommended to take two doses at the same time. If you overdose on Afanat 30 mg, contact your doctor immediately or seek medical help at the nearest hospital emergency department.
Рекомендации по безопасности
• Alcohol: It is generally not recommended to drink alcohol while taking Afanat 30 mg. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Afanat 30 mg Tablet is safe for use in patients with mild to moderate kidney disease, no dose adjustment of Afanat 30 mg Tablet is recommended. The use of Afanat 30 mg Tablet is not recommended for severe kidney disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Breastfeeding: It is not recommended to breastfeed while taking Afanat 30 mg Tablet. Afanat 30 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Afanat 30 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Afanat 30 mg Tablet is safe for use in patients with mild to moderate liver disease, no dose adjustment of Afanat 30 mg Tablet is recommended. The use of Afanat 30 mg is not recommended for severe liver disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Pregnancy: Use of Afanat 30 mg Tablet may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Afanat 30 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Afanat 30 mg Tablet may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Afanat 30 mg.
Отказ от ответственности
Компания Sidmex Inovia стремится предоставлять точную и достоверную информацию; однако весь контент на этом веб-сайте, включая описания и состав продуктов, предназначен только для информационных целей и не должен рассматриваться как замена профессиональной медицинской консультации, диагностики или лечения.
Пользователям рекомендуется проконсультироваться с квалифицированным медицинским специалистом, прежде чем принимать какие-либо медицинские решения. Предоставленная информация не должна использоваться для самодиагностики или самолечения.
Все перечисленные продукты предназначены исключительно для B2B и оптовых запросов. Sidmex Inovia не пропагандирует прямое использование потребителями и стремится поддерживать, а не заменять отношения между медицинским работником и пациентом.
Названия продуктов, товарные знаки и бренды принадлежат их соответствующим владельцам, и их использование не подразумевает какой-либо связи или одобрения. Sidmex Inovia не несет ответственности за любые последствия, возникающие в результате использования информации, предоставленной на этом веб-сайте.